FDA Adverse Event Injury Summary report: N

T:FLEX INSULIN DELIVERY SYSTEM

MDR report key: 6850049 · Received September 7, 2017

Report

Report Number
3007981285-2017-25491
Event Type
Injury
Date Received
September 7, 2017
Date of Event
August 18, 2017
Report Date
September 7, 2017
Manufacturer
TANDEM DIABETES CARE
Product Code
LZG
PMA / PMN Number
K143189
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MN, US
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

T:FLEX USER GUISE STATES: ONLY HUMALOG® AND NOVOLOG® HAVE BEEN TESTED BY TANDEM DIABETES CARE, INC., AND FOUND TO BE COMPATIBLE FOR USE IN THE T:FLEX SYSTEM. IT IS NOT INTENDED FOR USE WITH ANY OTHER DELIVERY SUBSTANCE. NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED. DEVICE NOT RETURNED.

Description of Event or Problem · 1

IT WAS REPORTED AN OCCLUSION ALARM OCCURRED. THE CUSTOMER'S BLOOD GLUCOSE (BG) LEVEL WAS 250MG/DL AND A CORRECTION BOLUS VIA THE PUMP WAS DELIVERED TO ADDRESS THE BG LEVEL. THE CUSTOMER PERFORMED TROUBLESHOOTING ON THEIR OWN PRIOR TO CONTACTING TANDEM TECHNICAL SUPPORT AND FOUND THE OCCLUSION TO BE WITHIN THE CARTRIDGE. REPORTEDLY, THE CUSTOMER USES U-500 INSULIN IN THEIR CARTRIDGE. CTS INFORMED THE CUSTOMER THAT U-500 IS CONTRAINDICATED FOR USE WITH THE PUMP. A CARTRIDGE CHANGE WAS PERFORMED TO ADDRESS THE OCCLUSION ALARM AND INSULIN DELIVERIES WERE RESUMED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
628930 T:FLEX INSULIN DELIVERY SYSTEM INFUSION PUMP LZG TANDEM DIABETES CARE 004628-005 M020664

Patients

Seq Age Sex Outcome Treatment
1 57 YR Other